Delivery Order SPE2DB22D1052-SPE2DB25FU9MN
Award Date
7/2/25
Potential Completion Date
7/24/25
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ATTRUBY 356 MG TABLET 28S, a pharmaceutical product, with a ceiling value of $12,778.22 and a performance period ending on June 25, 2025. The contract is a firm fixed-price delivery order and is not set aside for any particular business category. Amerisourcebergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ATTRUBY 356 MG TABLET 28S, a medical product, with a total ceiling value of $12,778.22. The contract type is Firm Fixed Price and the ultimate completion date is July 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp also holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,778.22 firm fixed-price contract is for the delivery of ATTRUBY 356 MG TABLET 28S, with an ultimate completion date of July 28, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, designated as SPE2DX, which provides a...
This federal contract award, valued at $12,778.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ATTRUBY 356 MG TABLET 28S, a pharmaceutical product, with a performance period ending on June 30, 2025. The contract is a delivery order, with a firm fixed-price pricing type. It is not set aside for any specific business category. Amerisourcebergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ATTRUBY 356 MG TABLET 28S. The contract has a ceiling value of $12,778.22 and a performance period through July 29, 2025. It is a firm fixed-price contract, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a significant vendor for DLA, holding a $999,999,999.00 Indefinite Delivery Contract...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), an agency within the Department of Defense. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $12,778.22 and with a completion date of June 27, 2025. The contract is for the delivery of ATTRUBY 356 MG TABLET 28S, a pharmaceutical product. Amerisourcebergen Drug Corp is a for-profit organization...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,778.22, is for the delivery of ATTRUBY 356 MG TABLET 28S, a pharmaceutical product. The contract has a performance period ending on May 22, 2025. The contract is not a set-aside and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is the prime contractor and is a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,778.22, is for the delivery of 4568039826 ATTRUBY 356 MG TABLET 28S. The contract is a firm fixed-price delivery order with a completion date of May 16, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and holds a larger...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $11,879.83 and a performance period through June 17, 2025. The contract is not set aside and allows Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies, including medications across various therapeutic areas, to support military...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,104.80 and a completion date of June 16, 2025. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the Defense Health Agency and U.S. Coast Guard. The company...